Impaired regulatory T-cell homeostasis due to vitamin D deficiency in undifferentiated connective tissue disease

References

• Bodolay E, Csiki Z, Szekanecz Z, Ben T, Kiss E, Zeher M, Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD). Clin Exp Rheumatol 2003;21:313–20.
   PubMed Web of Science ®Google Scholar
• Mosca M, Tani C, Neri C, Baldini C, Bombardieri S. Undifferentiated connective tissue diseases (UCTD). Autoimmun Rev 2006;6:1–4.
   PubMed Web of Science ®Google Scholar
• Mosca M, Tani C, Bombardieri S. Undifferentiated connective tissue diseases (UCTD): a new frontier for rheumatology. Best Pract Res Clin Rheumatol 2007;21:1011–23.
   PubMed Web of Science ®Google Scholar
• Danieli MG, Fraticelli P, Franceschini F, Cattaneo R, Farsi A, Passaleva A, Five-year follow-up of 165 Italian patients with undifferentiated connective tissue diseases. Clin Exp Rheumatol 1999;17:585–91.
   PubMed Web of Science ®Google Scholar
• Mosca M, Tavoni A, Neri R, Bencivelli W, Bombardieri S. Undifferentiated connective tissue diseases: the clinical and serological profiles of 91 patients followed for at least 1 year. Lupus 1998;7:95–100.
   PubMed Web of Science ®Google Scholar
• Szodoray P, Nakken B, Barath S, Gaal J, Aleksza M, Zeher M, Progressive divergent shifts in natural and induced T-regulatory cells signify the transition from undifferentiated to definitive connective tissue disease. Int Immunol 2008;20:971–9.
   PubMed Web of Science ®Google Scholar
• Bettelli E, Korn T, Oukka M, Kuchroo VK. Induction and effector functions of T(H)17 cells. Nature 2008;453:1051–7.
   PubMed Web of Science ®Google Scholar
• Harrington LE, Mangan PR, Weaver CT. Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol 2006;18:349–56.
   PubMed Web of Science ®Google Scholar
• Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005;6:1133–41.
   PubMed Web of Science ®Google Scholar
• Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L, Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 1999;42:963–70.
   PubMed Web of Science ®Google Scholar
• Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity 2004;21:467–76.
   PubMed Web of Science ®Google Scholar
• Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H, Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 2002;8:500–8.
   PubMed Web of Science ®Google Scholar
• Nakae S, Nambu A, Sudo K, Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 2003;171:6173–7.
   PubMed Web of Science ®Google Scholar
• Amadi-Obi A, Yu CR, Liu X, Mahdi RM, Clarke GL, Nussenblatt RB, TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med 2007;13:711–18.
   PubMed Web of Science ®Google Scholar
• Arnson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis 2007;66:1137–42.
   PubMed Web of Science ®Google Scholar
• Chun RF, Adams JS, Hewison M. Back to the future: a new look at ‘old’ vitamin D. J Endocrinol 2008;198:261–9.
   PubMed Web of Science ®Google Scholar
• DeLuca HF, Cantorna MT. Vitamin D: its role and uses in immunology. FASEB J 2001;15:2579–85.
   PubMed Web of Science ®Google Scholar
• Penna G, Amuchastegui S, Giarratana N, Daniel KC, Vulcano M, Sozzani S, 1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. J Immunol 2007;178:145–53.
   PubMed Web of Science ®Google Scholar
• Daniel C, Sartory NA, Zahn N, Radeke HH, Stein JM. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther 2008;324:23–33.
   PubMed Web of Science ®Google Scholar
• Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001;358:1500–3.
   PubMed Web of Science ®Google Scholar
• Kamen DL, Cooper GS, Bouali H, Shaftman SR, Hollis BW, Gilkeson GS. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 2006;5:114–17.
   PubMed Web of Science ®Google Scholar
• Littorin B, Blom P, Scholin A, Arnqvist HJ, Blohme G, Bolinder J, Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia 2006;49:2847–52.
   PubMed Web of Science ®Google Scholar
• Zold E, Szodoray P, Gaal J, Kappelmayer J, Csathy L, Gyimesi E, Vitamin D deficiency in undifferentiated connective tissue disease. Arthritis Res Ther 2008;10:R123.
   PubMed Web of Science ®Google Scholar
• Hollis BW, Wagner CL. Normal serum vitamin D levels. N Engl J Med 2005;352:515–16.
   PubMed Web of Science ®Google Scholar
• Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet 1998;351:805–6.
   PubMed Web of Science ®Google Scholar
• Cantorna MT, Mahon BD. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood) 2004;229:1136–42.
   PubMed Web of Science ®Google Scholar
• Kamen D, Aranow C. Vitamin D in systemic lupus erythematosus. Curr Opin Rheumatol 2008;20:532–7.
   PubMed Web of Science ®Google Scholar
• Patel S, Farragher T, Berry J, Bunn D, Silman A, Symmons D. Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum 2007;56:2143–9.
   PubMed Web of Science ®Google Scholar
• Cutolo M, Otsa K, Laas K, Yprus M, Lehtme R, Secchi ME, Circannual vitamin D serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. Clin Exp Rheumatol 2006;24:702–4.
   PubMed Web of Science ®Google Scholar
• Andjelkovic Z, Vojinovic J, Pejnovic N, Popovic M, Dujic A, Mitrovic D, Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients. Clin Exp Rheumatol 1999;17:453–6.
   PubMed Web of Science ®Google Scholar
• Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum 2004;50:72–7.
   PubMed Web of Science ®Google Scholar
• Munger KL, Zhang SM, O'Reilly E, Hernan MA, Olek MJ, Willett WC, Vitamin D intake and incidence of multiple sclerosis. Neurology 2004;62:60–5.
   PubMed Web of Science ®Google Scholar
• Cutolo M. Vitamin D or hormone D deficiency in autoimmune rheumatic diseases, including undifferentiated connective tissue disease. Arthritis Res Ther 2008;10:123.
   PubMed Web of Science ®Google Scholar
• Scharla SH, Schacht E, Lempert UG. Alfacalcidol versus plain vitamin D in inflammation induced bone loss. J Rheumatol Suppl 2005;76:26–32.
   PubMedGoogle Scholar
• Saadi HF, Dawodu A, Afandi BO, Zayed R, Benedict S, Nagelkerke N. Efficacy of daily and monthly high-dose calciferol in vitamin D-deficient nulliparous and lactating women. Am J Clin Nutr 2007;85:1565–71.
   PubMed Web of Science ®Google Scholar
• Shikari M, Kushida K, Yamazaki K, Nagai T, Inoue T, Orimo H. Effects of 2 years' treatment of osteoporosis with 1 alpha-hydroxy vitamin D3 on bone mineral density and incidence of fracture: a placebo-controlled, double-blind prospective study. Endocr J 1996;43:211–20.
   PubMed Web of Science ®Google Scholar
• Lei W, Luo Y, Yan K, Zhao S, Li Y, Qiu X, Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand J Rheumatol 2009;38:369–74.
   PubMed Web of Science ®Google Scholar
• Ramos HL, Valencia-Pacheco G, Alcocer-Varela J. Constitutive STAT3 activation in peripheral CD3(+) cells from patients with primary Sjogren's syndrome. Scand J Rheumatol 2008;37:35–9.
   PubMed Web of Science ®Google Scholar
• Szodoray P, Gal I, Barath S, Aleksza M, Horvath IF, Gergely P Jr, Immunological alterations in newly diagnosed primary Sjogren's syndrome characterized by skewed peripheral T-cell subsets and inflammatory cytokines. Scand J Rheumatol 2008;37:205–12.
   PubMed Web of Science ®Google Scholar
• Ait-Oufella H, Salomon BL, Potteaux S, Robertson AK, Gourdy P, Zoll J, Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 2006;12:178–80.
   PubMed Web of Science ®Google Scholar
• Cools N, Ponsaerts P, Van Tendeloo VF, Berneman ZN. Regulatory T cells and human disease. Clin Dev Immunol 2007;2007:89195.
   PubMedGoogle Scholar
• Jiao Z, Wang W, Jia R, Li J, You H, Chen L, Accumulation of FoxP3-expressing CD4+CD25+ T cells with distinct chemokine receptors in synovial fluid of patients with active rheumatoid arthritis. Scand J Rheumatol 2007;36:428–33.
   PubMed Web of Science ®Google Scholar
• Kukreja A, Cost G, Marker J, Zhang C, Sun Z, Lin-Su K, Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest 2002;109:131–40.
   PubMed Web of Science ®Google Scholar
• Liu MF, Wang CR, Fung LL, Wu CR. Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus. Scand J Immunol 2004;59:198–202.
   PubMed Web of Science ®Google Scholar
• Mottonen M, Heikkinen J, Mustonen L, Isomaki P, Luukkainen R, Lassila O. CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol 2005;140:360–7.
   PubMed Web of Science ®Google Scholar
• Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 2004;199:971–9.
   PubMed Web of Science ®Google Scholar
• Lindley S, Dayan CM, Bishop A, Roep BO, Peakman M, Tree TI. Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes 2005;54:92–9.
   PubMed Web of Science ®Google Scholar
• Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 2004;200:277–85.
   PubMed Web of Science ®Google Scholar
• Sugiyama H, Gyulai R, Toichi E, Garaczi E, Shimada S, Stevens SR, Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J Immunol 2005;174:164–73.
   PubMed Web of Science ®Google Scholar
• Balandina A, Lecart S, Dartevelle P, Saoudi A, Berrih-Aknin S. Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. Blood 2005;105:735–41.
   PubMed Web of Science ®Google Scholar
• Barath S, Sipka S, Aleksza M, Szegedi A, Szodoray P, Vegh J, Regulatory T cells in peripheral blood of patients with mixed connective tissue disease. Scand J Rheumatol 2006;35:300–4.
   PubMed Web of Science ®Google Scholar
• Alvarado-Sanchez B, Hernandez-Castro B, Portales-Perez D, Baranda L, Layseca-Espinosa E, Abud-Mendoza C, Regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 2006;27:110–18.
   PubMed Web of Science ®Google Scholar
• Lee JH, Wang LC, Lin YT, Yang YH, Lin DT, Chiang BL. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. Immunology 2006;117:280–86.
   PubMed Web of Science ®Google Scholar
• Lyssuk EY, Torgashina AV, Soloviev SK, Nassonov EL, Bykovskaia SN. Reduced number and function of CD4+CD25highFoxP3+ regulatory T cells in patients with systemic lupus erythematosus. Adv Exp Med Biol 2007;601:113–19.
   PubMed Web of Science ®Google Scholar
• Mellor-Pita S, Citores MJ, Castejon R, Tutor-Ureta P, Yebra-Bango M, Andreu JL, Decrease of regulatory T cells in patients with systemic lupus erythematosus. Ann Rheum Dis 2006;65:553–4.
   PubMed Web of Science ®Google Scholar
• Valencia X, Yarboro C, Illei G, Lipsky PE. Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol 2007;178:2579–88.
   PubMed Web of Science ®Google Scholar
• Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005;201:233–40.
   PubMed Web of Science ®Google Scholar
• Yen D, Cheung J, Scheerens H, Poulet F, McClanahan T, McKenzie B, IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 2006;116:1310–16.
   PubMed Web of Science ®Google Scholar
• Afzali B, Lombardi G, Lechler RI, Lord GM. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 2007;148:32–46.
   PubMed Web of Science ®Google Scholar
• Kurasawa K, Hirose K, Sano H, Endo H, Shinkai H, Nawata Y, Increased interleukin-17 production in patients with systemic sclerosis. Arthritis Rheum 2000;43:2455–63.
   PubMed Web of Science ®Google Scholar
• Wong CK, Lit LC, Tam LS, Li EK, Wong PT, Lam CW. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin Immunol 2008;127:385–93.
   PubMed Web of Science ®Google Scholar
• Penna G, Amuchastegui S, Cossetti C, Aquilano F, Mariani R, Sanvito F, Treatment of experimental autoimmune prostatitis in nonobese diabetic mice by the vitamin D receptor agonist elocalcitol. J Immunol 2006;177:8504–11.
   PubMed Web of Science ®Google Scholar
• Boonstra A, van Oudenaren A, Barendregt B, An L, Leenen PJ, Savelkoul HF. UVB irradiation modulates systemic immune responses by affecting cytokine production of antigen-presenting cells. Int Immunol 2000;12:1531–38.
   PubMed Web of Science ®Google Scholar
• Mattner F, Smiroldo S, Galbiati F, Muller M, Di Lucia P, Poliani PL, Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D(3). Eur J Immunol 2000;30:498–508.
   PubMed Web of Science ®Google Scholar